Natural History of HPV Infections in Men

男性 HPV 感染的自然史

基本信息

  • 批准号:
    7777130
  • 负责人:
  • 金额:
    $ 4.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-04-04 至 2011-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Promising results from prophylactic HPV vaccine trials support using these vaccines in cervical cancer prevention programs in the-future. Since vaccine coverage rarely if ever reaches 100%, population-level effectiveness of a prophylactic vaccine designed to prevent a sexually transmitted infection, such as an HPV vaccine, depends not only on the efficacy of the vaccine, but also on the incidence and duration of infection in both men and women. Although much has been learned about the epidemiology of human papillomavirus (HPV) infections in women, little is known about the incidence, determinants, and natural history of HPV infections in men. Research in men has been hampered, in part, by an inability to obtain adequate genital samples for HPV DNA testing. As discussed in this proposal, we developed a sensitive and acceptable method for sample collection and now propose to use this method in a prospective natural history study with the following aims. Among young men, (1) determine the incidence of infection with any type of HPV, oncogenic HPV, specific HPV types including HPV 16 and HPV6/11, and HPV 16 variants; (2) define risk 'factors for incident HPV infection, including lifetime and recent number of sex partners, circumcision status, condom use, frequency of vaginal intercourse, and courtship behavior; and (3) describe the natural history of HPV infection in men as measured by duration and levels of HPV DNA, HPV type-specific seroconversion, duration of antibodies, and development of genital warts. Our long-term goal is development of cost-effective approaches to the prevention of HPV-related cancers.
描述(由申请人提供):预防性 HPV 疫苗试验的良好结果支持在未来的宫颈癌预防计划中使用这些疫苗。由于疫苗覆盖率很少达到 100%,因此用于预防性传播感染的预防性疫苗(例如 HPV 疫苗)在人群中的有效性不仅取决于疫苗的功效,还取决于男性和女性的感染发生率和持续时间。尽管人们对女性人乳头瘤病毒 (HPV) 感染的流行病学了解很多,但对男性 HPV 感染的发病率、决定因素和自然史知之甚少。男性研究在一定程度上受到阻碍,因为无法获得足够的生殖器样本进行 HPV DNA 检测。正如本提案中所讨论的,我们开发了一种敏感且可接受的样本收集方法,现在建议在前瞻性自然历史研究中使用该方法,其目标如下。在年轻男性中,(1) 确定任何类型 HPV、致癌性的感染率 HPV,特定 HPV 类型,包括 HPV 16 和 HPV6/11,以及 HPV 16 变种; (2) 确定 HPV 感染的风险因素,包括一生和最近的性伴侣数量、包皮环切状况、安全套使用、阴道性交频率和求爱行为; (3) 描述男性 HPV 感染的自然史,通过 HPV DNA 的持续时间和水平、HPV 类型特异性血清转化、抗体持续时间和尖锐湿疣的发展来衡量。我们的长期目标是开发具有成本效益的方法来预防 HPV 相关癌症。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Disclosure of genital human papillomavirus infection to female sex partners by young men.
年轻男性向女性性伴侣披露生殖器人乳头瘤病毒感染。
  • DOI:
    10.1097/olq.0b013e318254c982
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Arima,Yuzo;Winer,RachelL;Kurth,AnnE;Martin,DianeP;Hughes,JamesP;Stern,MichaelE;Feng,Qinghua;Kiviat,NancyB;Koutsky,LauraA
  • 通讯作者:
    Koutsky,LauraA
Circumcision and acquisition of human papillomavirus infection in young men.
年轻男性的包皮环切术和人乳头瘤病毒感染。
  • DOI:
    10.1097/olq.0b013e31822e60cb
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Vanbuskirk,Kelley;Winer,RachelL;Hughes,JamesP;Feng,Qinghua;Arima,Yuzo;Lee,Shu-Kuang;Stern,MichaelE;O'Reilly,SandraF;Koutsky,LauraA
  • 通讯作者:
    Koutsky,LauraA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LAURA A KOUTSKY其他文献

LAURA A KOUTSKY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LAURA A KOUTSKY', 18)}}的其他基金

Disclosure of High-Risk HPV Infection to Sex Partners of Young Men
向年轻男性性伴侣披露高危 HPV 感染情况
  • 批准号:
    7660554
  • 财政年份:
    2009
  • 资助金额:
    $ 4.3万
  • 项目类别:
HPV Oral-Pharyngeal Study
HPV 口咽研究
  • 批准号:
    7896603
  • 财政年份:
    2009
  • 资助金额:
    $ 4.3万
  • 项目类别:
Disclosure of High-Risk HPV Infection to Sex Partners of Young Men
向年轻男性性伴侣披露高危 HPV 感染情况
  • 批准号:
    7899724
  • 财政年份:
    2009
  • 资助金额:
    $ 4.3万
  • 项目类别:
HPV Oral-Pharyngeal Study
HPV 口咽研究
  • 批准号:
    7708006
  • 财政年份:
    2009
  • 资助金额:
    $ 4.3万
  • 项目类别:
Natural History of HPV Infections in Men
男性 HPV 感染的自然史
  • 批准号:
    6914590
  • 财政年份:
    2005
  • 资助金额:
    $ 4.3万
  • 项目类别:
Natural History of HPV Infections in Men
男性 HPV 感染的自然史
  • 批准号:
    7575278
  • 财政年份:
    2005
  • 资助金额:
    $ 4.3万
  • 项目类别:
Natural History of HPV Infections in Men
男性 HPV 感染的自然史
  • 批准号:
    7681426
  • 财政年份:
    2005
  • 资助金额:
    $ 4.3万
  • 项目类别:
Natural History of HPV Infections in Men
男性 HPV 感染的自然史
  • 批准号:
    7368063
  • 财政年份:
    2005
  • 资助金额:
    $ 4.3万
  • 项目类别:
Natural History of HPV Infections in Men
男性 HPV 感染的自然史
  • 批准号:
    7214630
  • 财政年份:
    2005
  • 资助金额:
    $ 4.3万
  • 项目类别:
Natural History of HPV Infections in Men
男性 HPV 感染的自然史
  • 批准号:
    7049323
  • 财政年份:
    2005
  • 资助金额:
    $ 4.3万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 4.3万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.3万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 4.3万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.3万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 4.3万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 4.3万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.3万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 4.3万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 4.3万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.3万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了